| Prevalence of and risk factors for hepatic steatosis in Northern Italy S Bellentani, G Saccoccio, F Masutti, LS Crocè, G Brandi, F Sasso, ... Annals of internal medicine 132 (2), 112-117, 2000 | 1926 | 2000 |
| The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses V Gaboriau-Routhiau, S Rakotobe, E Lecuyer, I Mulder, A Lan, ... Immunity 31 (4), 677-689, 2009 | 1696 | 2009 |
| Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo … AX Zhu, YK Kang, CJ Yen, RS Finn, PR Galle, JM Llovet, E Assenat, ... The lancet oncology 20 (2), 282-296, 2019 | 1680 | 2019 |
| Drinking habits as cofactors of risk for alcohol induced liver damage S Bellentani, G Saccoccio, G Costa, C Tiribelli, F Manenti, M Sodde, ... Gut 41 (6), 845-850, 1997 | 947 | 1997 |
| Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double … KM Zhu AX, Park JO, Ryoo BY, Yen CJ, Poon R, Pastorelli D, Blanc JF, Chung ... Lancet Oncology 16 (7), 859-70, 2015 | 939 | 2015 |
| Cholangiocarcinoma: Epidemiology and risk factors SA Khan, S Tavolari, G Brandi Liver International 39, 19-31, 2019 | 700 | 2019 |
| Clinical patterns of hepatocellular carcinoma (hcc) in non alcoholic fatty liver disease (NAFLD): A multicenter prospective study BS Piscaglia F, Svegliati-Baroni G, Barchetti A, Pecorelli A, Marinelli S ... Hepatology, 2015 | 642* | 2015 |
| Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention D Colussi, G Brandi, F Bazzoli, L Ricciardiello International journal of molecular sciences 14 (8), 16365-16385, 2013 | 582 | 2013 |
| Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a … RK Kelley, M Ueno, C Yoo, RS Finn, J Furuse, Z Ren, T Yau, HJ Klümpen, ... The Lancet 401 (10391), 1853-1865, 2023 | 514 | 2023 |
| Interactions between commensal bacteria and gut sensorimotor function in health and disease G Barbara, V Stanghellini, G Brandi, C Cremon, G Di Nardo, R De Giorgio, ... Official journal of the American College of Gastroenterology| ACG 100 (11 …, 2005 | 436 | 2005 |
| Can current preoperative imaging be used to detect microvascular invasion of hepatocellular carcinoma? M Renzulli, S Brocchi, A Cucchetti, F Mazzotti, C Mosconi, C Sportoletti, ... Radiology 279 (2), 432-442, 2016 | 360 | 2016 |
| Fungal dysbiosis in mucosa-associated microbiota of Crohn’s disease patients G Liguori, B Lamas, ML Richard, G Brandi, G Da Costa, TW Hoffmann, ... Journal of Crohn's and Colitis 10 (3), 296-305, 2016 | 336 | 2016 |
| PD-L1, TMB, MSI, and other predictors of response to immune checkpoint inhibitors in biliary tract cancer A Rizzo, AD Ricci, G Brandi Cancers 13 (3), 558, 2021 | 239 | 2021 |
| High prevalence of celiac disease in Italian general population U Volta, S Bellentani, FB Bianchi, G Brandi, L De Franceschi, L Miglioli, ... Digestive diseases and sciences 46, 1500-1505, 2001 | 234 | 2001 |
| Mucosa-associated microbiota dysbiosis in colitis associated cancer ML Richard, G Liguori, B Lamas, G Brandi, G Da Costa, TW Hoffmann, ... Gut microbes 9 (2), 131-142, 2018 | 199 | 2018 |
| Hypersensitivity reactions related to oxaliplatin (OHP) G Brandi, MA Pantaleo, C Galli, A Falcone, A Antonuzzo, P Mordenti, ... British journal of cancer 89 (3), 477-481, 2003 | 178 | 2003 |
| Metastatic pancreatic cancer: is gemcitabine still the best standard treatment? M Di Marco, R Di Cicilia, M Macchini, E Nobili, S Vecchiarelli, G Brandi, ... Oncology reports 23 (5), 1183-1192, 2010 | 175 | 2010 |
| Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival G Ercolani, G Vetrone, GL Grazi, O Aramaki, M Cescon, M Ravaioli, ... Annals of surgery 252 (1), 107-114, 2010 | 174 | 2010 |
| Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties G Biasco, E Derenzini, GL Grazi, G Ercolani, M Ravaioli, MA Pantaleo, ... Cancer treatment reviews 32 (3), 214-228, 2006 | 151 | 2006 |
| Effect of vitamin A, C, and E supplementation on rectal cell proliferation in patients with colorectal adenomas GM Paganelli, G Biasco, G Brandi, R Santucci, G Gizzi, V Villani, M Cianci, ... JNCI: Journal of the National Cancer Institute 84 (1), 47-52, 1992 | 148 | 1992 |
